Trending
US Allows Anthropic to Release Mythos to 'Trusted Partners' in Ongoing AI Regulation DebateSmall Businesses, Big Impact: Five Ways the UN is Helping MSMEs Drive Sustainable DevelopmentOpenAI Launches Limited Release of New AI Model in US Only, Amid Growing Government ScrutinyKBRA Comments on Colony Bancorp, Inc.'s Proposed Merger with First Reliance Bancshares, Inc.Apple Loop: iPhone 18 Pro Release Date, Hidden iOS 27 Features, iPhone Air 2 Details and MoreSaks Emerges from Bankruptcy with a New Plan and Corporate NameCould AI Eventually Make Things Cheaper?John John Florence Gives a Tour of the Vela, the Catamaran He Calls HomeHikers Lost in Kosciuszko National Park Rescued by Drones Powered by Artificial IntelligenceUS Rapist Who Fled to Scotland After Appearing to Fake Own Death Dies in HospitalAll Aboard for Anker's Prime Day Deals on Headphones, Earbuds, Power Stations, and MoreRice Unveils Shape-Shifting Surface for Future Technological AdvancementsAmazon Prime Day is Almost Over - These Are the 45 Best (and Most Popular) Deals in Canada, Up to 80% Off | Live UpdatesWho Owns NZ GPs: The Private Equity Giants, Kiwi Corporates, and the DoctorsShrinking Properties Force Home Brewers to Go Compact: Adapting to Smaller Spaces in the Face of UrbanizationCorrecting and Replacing Ridge Security Named a Sample Vendor in the 2026 Gartner Hype Cycle for Security OperationsUS Allows Anthropic to Release Mythos to 'Trusted Partners' in Ongoing AI Regulation DebateSmall Businesses, Big Impact: Five Ways the UN is Helping MSMEs Drive Sustainable DevelopmentOpenAI Launches Limited Release of New AI Model in US Only, Amid Growing Government ScrutinyKBRA Comments on Colony Bancorp, Inc.'s Proposed Merger with First Reliance Bancshares, Inc.Apple Loop: iPhone 18 Pro Release Date, Hidden iOS 27 Features, iPhone Air 2 Details and MoreSaks Emerges from Bankruptcy with a New Plan and Corporate NameCould AI Eventually Make Things Cheaper?John John Florence Gives a Tour of the Vela, the Catamaran He Calls HomeHikers Lost in Kosciuszko National Park Rescued by Drones Powered by Artificial IntelligenceUS Rapist Who Fled to Scotland After Appearing to Fake Own Death Dies in HospitalAll Aboard for Anker's Prime Day Deals on Headphones, Earbuds, Power Stations, and MoreRice Unveils Shape-Shifting Surface for Future Technological AdvancementsAmazon Prime Day is Almost Over - These Are the 45 Best (and Most Popular) Deals in Canada, Up to 80% Off | Live UpdatesWho Owns NZ GPs: The Private Equity Giants, Kiwi Corporates, and the DoctorsShrinking Properties Force Home Brewers to Go Compact: Adapting to Smaller Spaces in the Face of UrbanizationCorrecting and Replacing Ridge Security Named a Sample Vendor in the 2026 Gartner Hype Cycle for Security Operations

House Leaders Visit Unilab Manufacturing Facility in Laguna, Highlighting Importance of Local Pharmaceutical Industry

House Committee on Trade and Industry Chair Rep. Maximo Dalog Jr. and House Committee on Health Chair Rep. Ciriaco B. Gato Jr. recently visited Amherst......

News Desk

Staff Writer

Published

Jun 27, 2026

Source

Manila Bulletin

Analytics

0 0 0
House Leaders Visit Unilab Manufacturing Facility in Laguna, Highlighting Importance of Local Pharmaceutical Industry

AI Insight:The visit underscores the government's commitment to supporting the domestic pharmaceutical sector.

House Committee on Trade and Industry Chair Rep. Maximo Dalog Jr. and House Committee on Health Chair Rep. Ciriaco B. Gato Jr. recently paid a visit to Unilab's manufacturing facility in Laguna, seeking a firsthand understanding of the company's operations and production processes. Their visit was a key component of their ongoing efforts to support the local pharmaceutical industry, which has been grappling with a multitude of challenges in recent years. These include regulatory hurdles and intense competition from cheaper imported products, which have put the industry under significant pressure to produce high-quality products at a reasonable cost.

Unilab, one of the Philippines' largest pharmaceutical companies, has been a stalwart in the industry, providing essential medicines and vaccines to millions of Filipinos. The company has also been at the forefront of innovation, developing new products and technologies to address the country's growing healthcare needs. Its commitment to research and development has been particularly noteworthy, with the company investing heavily in the creation of new medicines and treatments.

The visit to Unilab's manufacturing facility comes at a critical juncture for the pharmaceutical industry. The industry has been plagued by issues such as counterfeiting, substandard products, and lack of access to essential medicines, particularly in rural areas. The government has been working to address these issues through various initiatives, including the passage of the Philippine Medicine Law. This law aims to improve the regulation of the industry and ensure the availability of safe and effective medicines, while also providing incentives for local manufacturers to invest in research and development.

Unilab has been a pioneer in the development of generic medicines in the Philippines, helping to increase access to affordable healthcare for millions of Filipinos. The company's commitment to innovation has also been evident in its development of new products and technologies, such as a range of medicines for the treatment of non-communicable diseases like diabetes and hypertension. These diseases are major public health concerns in the Philippines, and Unilab's efforts to address them are to be commended.

The visit to Unilab's manufacturing facility is also seen as a boost to the country's economic development. The pharmaceutical industry is a significant contributor to the country's GDP, and the government has set ambitious targets to increase its output and exports. The industry has also been identified as a key sector for investment, with the government offering various incentives to attract foreign and local investors.

The global pharmaceutical market is expected to reach $1.5 trillion by 2025, driven by the increasing demand for high-quality medicines and vaccines. The Philippines has significant opportunities to tap into this market, particularly in the areas of generic medicines and biotechnology. However, the industry faces significant challenges, including regulatory hurdles, competition from cheaper imported products, and lack of access to funding and resources.

The government has been working to address these issues through various initiatives, including the passage of the Philippine Medicine Law. The visit to Unilab's manufacturing facility also highlights the importance of collaboration between the public and private sectors in supporting the growth and development of the pharmaceutical industry. Unilab has been working closely with the government to develop new products and technologies, and to improve the availability of essential medicines.

The partnership between the public and private sectors is critical for the industry's growth and competitiveness. It is expected to play a key role in the development of the country's healthcare sector, which is a key component of the sector. The industry has significant opportunities for growth and development, and the government is committed to supporting its progress.

As Rep. Dalog noted, 'The visit to Unilab's manufacturing facility is a testament to the government's commitment to supporting the local pharmaceutical industry. We recognize the importance of this industry to the country's economic development, and are working to address the challenges facing it. We believe that the industry has significant opportunities for growth and development, and are committed to supporting its progress.'

The visit to Unilab's manufacturing facility is a significant development for the pharmaceutical industry in the Philippines. It highlights the importance of collaboration between the public and private sectors, and underscores the government's commitment to supporting the industry's growth and development. As the industry continues to face challenges, it is expected to play a key role in the development of the country's healthcare sector.